Observational Study of Decentralized Urine Optical Interaction Patterns Associated With Environmental Microplastic and Nanoplastic Exposure
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
A Multi-Center Observational Trial of Symptomatic, High-Risk Bone Metastases Treated With Percutaneous Ablation and Palliative Radiation Therapy
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
Popular cities in Minnesota
Minnesota offers a strong healthcare network and renowned medical research institutions, making it a prominent hub for a wide range of clinical trials. Leading organizations such as the Mayo Clinic, University of Minnesota Medical School, and Hennepin Healthcare are at the forefront of cutting-edge research.
These institutions are recognized globally for their contributions to medical advancements, placing Minnesota as a key player in clinical trials across various medical fields, from cancer and cardiovascular research to neurological and rare diseases.
Why choose Minnesota for clinical trials?
For people considering participation in a clinical trial, Minnesota provides distinct advantages. The state is home to a diverse and engaged population, which enriches the pool of participants and enhances the relevance of research findings. Minnesota is also renowned for its innovative healthcare landscape, highlighted by institutions that are at the forefront of medical research and technological advancements.
By choosing to participate in a clinical trial in Minnesota, participants can contribute to significant medical research while benefiting from a well-established and collaborative clinical research environment that prioritizes patient safety and care.
Common conditions studied in Minnesota
Minnesota is a prominent center for clinical research, particularly known for its focus on several key medical conditions.
Diabetes and metabolic disorders
Minnesota has made significant contributions to diabetes research, especially regarding Type 1 diabetes. The University of Minnesota’s Diabetes Institute conducts clinical trials focused on prevention strategies, management techniques, and innovative therapies, including potential immunotherapies and artificial pancreas systems.
Given the rising prevalence of diabetes in the region, these studies aim to address both immediate patient needs and long-term public health challenges associated with metabolic disorders.
Cancer
The Mayo Clinic is a global leader in oncology research, conducting extensive clinical trials on a wide range of cancers, including breast, prostate, lung, and pancreatic cancer. Its comprehensive cancer center in Minnesota is distinguished for its pioneering work in personalized medicine and immunotherapy, utilizing advanced genomic techniques to tailor treatments to individual patients.
Oncology research carried out in Minnesota aims to enhance therapeutic efficacy and minimize side effects, contributing significantly to improved survival rates and quality of life for cancer patients.
Neurological disorders
The state of Minnesota is particularly renowned for its research on neurological conditions, including Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis (MS). The Mayo Clinic and the University of Minnesota lead extensive studies exploring new diagnostic tools and treatment modalities. These trials investigate everything from pharmacological therapies to lifestyle interventions that can help slow disease progression or improve symptoms.
Cardiovascular diseases
Minnesota has a robust focus on cardiovascular health, with leading institutions like the University of Minnesota actively conducting trials on heart disease, heart failure, and stroke prevention. Research efforts in Minnesota often explore innovative interventions, such as new surgical techniques, minimally invasive procedures, and advanced medical devices, including stents and pacemakers.
The state’s commitment to cardiovascular research not only aims to improve patient outcomes but also seeks to develop effective strategies for managing risk factors like hypertension and diabetes.
Mental health conditions
Minnesota prioritizes mental health research, studying various conditions such as depression, anxiety, and schizophrenia. Clinical trials in this area focus on new pharmacological treatments, psychotherapeutic interventions, and alternative therapies, including mindfulness and behavioral approaches.
Minnesota research institutions are dedicated to developing effective treatment modalities that can help improve mental health outcomes and reduce the stigma associated with mental illness.
Rare diseases
Institutions like the Mayo Clinic in Minnesota are at the forefront of research on rare genetic and metabolic disorders, conducting clinical trials aimed at developing targeted therapies and enhancing the understanding of these conditions. These trials are vital for patients who often face limited treatment options.
Rare diseases being studied include cystic fibrosis, muscular dystrophy, hemophilia, and amyotrophic lateral sclerosis (ALS), among others. By exploring genetic therapies and novel drug candidates, researchers aim to provide new hope for individuals affected by these challenging conditions.
Local regulations and guidelines
In Minnesota, clinical trials are governed by both federal and state regulations to ensure the safety and rights of participants. Key federal guidelines include the requirements set by the Food and Drug Administration (FDA) and the Office for Human Research Protections (OHRP), which mandate Institutional Review Board (IRB) approval, informed consent, and adherence to Good Clinical Practice (GCP) standards.
At state level, Minnesota has specific laws that align with federal protections for human subjects, emphasizing the importance of ethical oversight in medical research. The Minnesota Department of Health plays a role in overseeing health research initiatives, and ensuring compliance with public health regulations. Additionally, local institutions have established rigorous internal policies and IRBs to safeguard participant rights and maintain high research standards. This collaborative framework fosters a supportive environment for conducting clinical trials while prioritizing participant welfare.
Benefits of participating in clinical trials
Clinical trial participation provides individuals with a unique opportunity to access groundbreaking treatments and therapies that are not yet widely available. This is especially advantageous for those whose conditions have not improved with standard treatments. Participants also benefit from access to dedicated medical professionals who closely monitor their health throughout the trial, ensuring safety while evaluating the effectiveness of new interventions.
Moreover, engaging in clinical trials is vital for the progress of medical research. By becoming participants, individuals not only gain access to potentially life-changing therapies but also contribute to the advancement of healthcare practices on a global scale. Involvement in clinical research can lead to significant discoveries that enhance our understanding of diseases and improve treatment options, ultimately offering new hope to many patients facing challenging health issues.
Interested in participating in clinical trials but worried about how long they might take? Check out our comprehensive guide for all the information you need to make an informed decision.
How to enroll in a clinical trial in Minnesota
Enrolling in a clinical trial through our platform is a straightforward and user-friendly process. Here's how to get started:
- Identify your trial: Use our intuitive search bar or filter options to locate clinical trials specific to requirements. This first step simplifies the process of finding relevant research studies tailored to your needs.
- Select your preferred location: To find trials conveniently located near you, simply input your preferred location into the dedicated filter bar on the left-hand side of the page.
- Explore study details: For in-depth information about each study, simply click the “Learn More” button. This will provide you with comprehensive details about the trial, including objectives, procedures, and eligibility criteria.
- Complete the health profile: After clicking on the “Get started” button you will be taken to our efficient 5-step application process to provide important health information. This helps us match you with the clinical trial that best fits your needs.
- Submit the application: After completing the application, send it in. A clinical trial coordinator will review it and contact you regarding the possibility of participation.